Study Title: Clinical Outcomes of Prolensa (Bromfenac Ophthalmic Solution) 0.07% QD vs. Ilevro (Nepafenac Ophthalmic Suspension) 0.3% QD With Extra (Pulse) Dose on Day of Surgery for Treatment of Ocular Inflammation Associated With Cataract Surgery in a Randomized, Single Masked Clinical Trial

Clinical trial NCT03886779 · COMPLETED

Trial details

NCT number

NCT03886779

Sponsor

Silverstein Eye Centers

Status

COMPLETED

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2013-10-30

Primary completion

2017-02-15

Enrollment

57

View on ClinicalTrials.gov